Establishment of an in vitro cholestasis risk assessment system using two-dimensional cultured HepaRG cells and 12 bile acids
The Journal of Toxicological Sciences · 2023
DOI: 10.2131/jts.48.47 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Toxicological Sciences, 2023. Verfasst von Toshihisa Koga und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug Metabolism and Pharmacokinetics, Nonclinical Research Center, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd. Hauptthemen laut MEDLINE: Chemical and Drug Induced Liver Injury, Cholestasis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Drug Metabolism and Pharmacokinetics, Nonclinical Research Center, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd.
Zitieren
APA
Koga, T., Takeuchi, K., & Umehara, K. (2023). Establishment of an in vitro cholestasis risk assessment system using two-dimensional cultured HepaRG cells and 12 bile acids. The Journal of Toxicological Sciences. https://doi.org/10.2131/jts.48.47
Vancouver
Koga T, Takeuchi K, Umehara K. Establishment of an in vitro cholestasis risk assessment system using two-dimensional cultured HepaRG cells and 12 bile acids. The Journal of Toxicological Sciences. 2023. doi:10.2131/jts.48.47
BibTeX
@article{Koga2023,
author = {Koga, Toshihisa and Takeuchi, Kenji and Umehara, Ken},
title = {Establishment of an in vitro cholestasis risk assessment system using two-dimensional cultured HepaRG cells and 12 bile acids},
journal = {The Journal of Toxicological Sciences},
year = {2023},
doi = {10.2131/jts.48.47}
}
EUVIMED